Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851706 · ClinicalTrials.gov registry record
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
A clinical trial of Brain Tumor and Brain Cancer, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,214
- Enrollment target
- 1
- Study location
NCT02851706 is a study of Brain Tumor and Brain Cancer that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,214 participants, above the 264-participant average among 69 other Brain Tumor trials with a reported enrollment target (360% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02851706, a study of Brain Tumor and Brain Cancer, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,214 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Brain and spinal cord tumors are uncommon. But they contribute substantially to cancer deaths in the U.S. in children and adults. Little progress has been made in treating brain tumors. Researchers want to learn more about these tumors by studying people who have them. Objectives: To understand brain and spinal cord tumors better and uncover areas for further research. Also, to connect people with these tumors to doctors who can help them manage their illness and give them new treatment options. Design: Participants will have an initial (baseline) visit. They will have their medical history taken and undergo physical and neurological exams. They will have blood tests. They may have scans (imaging studies) of the nervous system. If participants have urine or cerebrospinal fluid collected during their regular care, researchers may save some. Brain tumor tissue from a prior surgery may be studied. Genomic DNA testing will be done on samples. Results will be linked to participants medical and/or family history. The number of study visits at NIH will depend on the wishes of participants and their local doctors. Participants will take a brain tumor survey on a computer. They can take it all at once or in 6 separate sections. Participants will answer questions about their general well-being. They will answer questions to learn if they have symptoms of depression or anxiety. Physicians will discuss test results with participants. They will recommend management and treatment options.
Conditions Studied
Interventions
- OTHER No Treatment
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,214 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2025-05-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02851706
The ClinicalTrials.gov registry entry for NCT02851706 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,214 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 264-participant average among 69 other Brain Tumor trials with a reported enrollment target (360% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Brain Tumor appearing as the primary indexed condition, and to 1 intervention - of which No Treatment is the first listed.
NCT02851706 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02851706 about?
NCT02851706 is a clinical study titled "Natural History of and Specimen Banking for People With Tumors of the Central Nervous System". Background: Brain and spinal cord tumors are uncommon. But they contribute substantially to cancer deaths in the U.S. in children and adults. Little progress has been made in treating brain tumors. Researchers want to learn more about these tumors by studying people who have them. Objectives: To ...
What is the current status of trial NCT02851706?
This trial is currently completed. The enrollment target is 1,214 participants. The study started on 2016-09-01. Estimated completion is 2025-05-29.
What conditions does trial NCT02851706 study?
This clinical trial studies the following conditions: Brain Tumor, Brain Cancer, Neoplasm, Spine Tumor, Spine Cancer.
What interventions are being tested in trial NCT02851706?
The interventions under investigation include: No Treatment (OTHER).
Who is sponsoring clinical trial NCT02851706?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02851706 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
RECRUITING
-
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RECRUITING · Phase 1
-
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
RECRUITING · NA
-
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
RECRUITING · Phase 1
-
Brodalumab in the Treatment of Immune-Related Adverse Events
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.